| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2011 | WO2011075621A1 Compositions and methods for ophthalmic delivery of nasal decongestants |
| 06/23/2011 | WO2011075620A1 Method for treating haematological cancers |
| 06/23/2011 | WO2011075617A1 Compositions and methods for eye whitening |
| 06/23/2011 | WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | WO2011075613A1 Azaindole derivatives, their preparation and their therapeutic application |
| 06/23/2011 | WO2011075607A1 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | WO2011075596A1 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/23/2011 | WO2011075592A1 Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
| 06/23/2011 | WO2011075591A1 Anti parasitic dihydroazole compounds and compositions comprising same |
| 06/23/2011 | WO2011075565A1 SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-Aα MODULATORS |
| 06/23/2011 | WO2011075560A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075539A2 Treatment of obesity or diabetes with bile acid sequestrants |
| 06/23/2011 | WO2011075537A1 Compounds for the treatment of neurologic disorders |
| 06/23/2011 | WO2011075525A1 Process for preparing cannabinoid receptor ligands |
| 06/23/2011 | WO2011075517A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075515A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075514A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |
| 06/23/2011 | WO2011075487A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders |
| 06/23/2011 | WO2011075470A1 Quaternary piperidine compounds and uses thereof |
| 06/23/2011 | WO2011075462A1 Agent that interacts with serum amyloid a gene for the treatment of glaucoma |
| 06/23/2011 | WO2011075431A1 Coffee treatment method |
| 06/23/2011 | WO2011075415A1 Bridged bicyclic rho kinase inhibitor compounds, composition and use |
| 06/23/2011 | WO2011075391A1 Formulations of acadesine |
| 06/23/2011 | WO2011075375A1 Fused tricyclic compounds for the treatment of inflammatory disorders |
| 06/23/2011 | WO2011075371A1 Pyridoquinazolinone m1 receptor positive allosteric modulators |
| 06/23/2011 | WO2011075334A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/23/2011 | WO2011075267A1 Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
| 06/23/2011 | WO2011075210A2 Small molecules that covalently modify transthyretin |
| 06/23/2011 | WO2011075188A1 Dicer substrate agents and methods for the specific inhibition of gene expression |
| 06/23/2011 | WO2011075136A1 Chalcones as enhancer of antimicrobial agents |
| 06/23/2011 | WO2011075052A1 Novel 3´-deoxy-3´-methylidene- -l-nucleosides |
| 06/23/2011 | WO2011075032A1 Tumour treatment agents and method |
| 06/23/2011 | WO2011075004A1 Anti-thrombosis aptamers and method for stabilizing the structure thereof |
| 06/23/2011 | WO2011074992A1 Treatment composition and method |
| 06/23/2011 | WO2011074903A2 Pharmaceutical composition containing a3 adenosine receptor agonist |
| 06/23/2011 | WO2011074881A2 Substances for inhibiting expression of genes for sensitivity to allergic disorders |
| 06/23/2011 | WO2011074791A2 Pharmaceutical composition containing telmisartan and hydrochlorothiazide |
| 06/23/2011 | WO2011074743A1 Granules comprising fenofibrate adsorbed on carrier surface and pharmaceutical composition comprising the same |
| 06/23/2011 | WO2011074695A1 Shivering suppressor |
| 06/23/2011 | WO2011074675A1 Process for preparation of spiroketal derivative |
| 06/23/2011 | WO2011074660A1 Elution-stabilized preparation |
| 06/23/2011 | WO2011074658A1 Novel anti-platelet agent |
| 06/23/2011 | WO2011074652A1 Nucleic acid capable of inhibiting expression of hif-2α |
| 06/23/2011 | WO2011074643A1 Prophylactic or ameliorating agent fo pigmentation |
| 06/23/2011 | WO2011074637A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074636A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074635A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074608A1 Prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011074607A1 Triterpene derivative, and prophylactic or therapeutic agent for chronic hepatitis c |
| 06/23/2011 | WO2011074567A1 Transdermal preparation containing basic anti-inflammatory agent |
| 06/23/2011 | WO2011074566A1 Felbinac-containing transdermal absorption preparation |
| 06/23/2011 | WO2011074565A1 Piroxicam-containing endermic preparation |
| 06/23/2011 | WO2011074560A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | WO2011074519A1 Pharmaceutical composition for treatment and prevention of age-related memory impair |
| 06/23/2011 | WO2011074377A1 Composition containing protopanaxatriol and protopanaxadiol |
| 06/23/2011 | WO2011074275A1 Skin barrier function promoter |
| 06/23/2011 | WO2011073998A1 Composition of dexibuprofen transdermal hydrogel |
| 06/23/2011 | WO2011073985A1 Compositions and methods of counteracting residual sedative effects of sleep/ hypnotic drugs |
| 06/23/2011 | WO2011073984A1 Methods for the treatment of speech impediments |
| 06/23/2011 | WO2011073981A2 Compositions and methods for treating somnolence |
| 06/23/2011 | WO2011073929A1 6-(2-furyl)-3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylate derivatives and uses thereof |
| 06/23/2011 | WO2011073907A1 A polymorph form of nevirapine and its preparation |
| 06/23/2011 | WO2011073845A1 N-linked hydroxamic acid derivatives useful as antibacterial agents |
| 06/23/2011 | WO2011073788A2 Balaglitazone compositions and methods |
| 06/23/2011 | WO2011073739A1 Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma |
| 06/23/2011 | WO2011073685A1 Modulator |
| 06/23/2011 | WO2011073662A1 Combination of a benzoxazinone and a further agent for treating respiratory diseases |
| 06/23/2011 | WO2011073647A1 Therapeutic combinations of theobromine and an antihistamine |
| 06/23/2011 | WO2011073646A1 Combination of theobromine with a decongestant and its use for the treatment of cough |
| 06/23/2011 | WO2011073492A1 Derivatives of aminocyclitols, obtainment procedure and uses |
| 06/23/2011 | WO2011073489A1 Use of raltegravir and derivatives for producing medicaments for the treatment of infections caused by the herpes virus |
| 06/23/2011 | WO2011073482A1 Compounds having anti-inflammatory activity |
| 06/23/2011 | WO2011073479A1 Use of seconeolitsine and n-methyl-seconeolitsine for the manufacture of medicaments |
| 06/23/2011 | WO2011073473A1 Vinyl sulphone functionalised lipid systems. synthesis and uses |
| 06/23/2011 | WO2011073437A2 Bacteriocin- and prebiotic-based cosmetic or dermatological compositions |
| 06/23/2011 | WO2011073419A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance |
| 06/23/2011 | WO2011073408A2 Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| 06/23/2011 | WO2011073395A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | WO2011073392A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | WO2011073378A1 Tricyclic antibiotics |
| 06/23/2011 | WO2011073347A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| 06/23/2011 | WO2011073339A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| 06/23/2011 | WO2011073322A1 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs |
| 06/23/2011 | WO2011073316A1 4-aryl-butane-1,3-diamides |
| 06/23/2011 | WO2011073299A1 Pyridinyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 06/23/2011 | WO2011073298A1 Tetrazole derivatives as nicotinic acetylcholine receptor modulators |
| 06/23/2011 | WO2011073297A1 Tetrazole derivatives as nicotinic acetylcholine receptor moudlators |
| 06/23/2011 | WO2011073296A1 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 06/23/2011 | WO2011073286A1 Prostate specific membrane antigen inhibitors |
| 06/23/2011 | WO2011073281A1 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
| 06/23/2011 | WO2011073277A1 PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS |
| 06/23/2011 | WO2011073276A1 Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073273A1 Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073269A1 Piperidine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073263A1 1, 7 - diazacarbazoles and their use in the treatment of cancer |
| 06/23/2011 | WO2011073248A1 Use of compounds in the treatment or prevention of skin disorders |
| 06/23/2011 | WO2011073231A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES |
| 06/23/2011 | WO2011073218A1 Compositons and methods for inhibiting expression of il-18 genes |
| 06/23/2011 | WO2011073211A1 Combretastatin derivatives and uses therefor |
| 06/23/2011 | WO2011073205A1 Combination of carotenoids and epi-lutein |